Back to Atlas
BSemi-durableStandard research/education caution
CMP-0228
Supplement/research
Palmitoylethanolamide / PEA
Anti-inflammatory / Neuroprotection
Pain and inflammation modulation
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Lipid amide
- Primary mechanism
- PPAR-alpha and mast-cell modulation
- Primary market use
- Pain/inflammation
Pharmacology
- Molecular weight (Da)
- 299.5
- Oral bioavailability
- Oral; low-moderate
- Half-life
- ~6-8 h
- Route tags
- Route-dependent / verify
- Evidence level
- Human/supplement
- Clinical status
- Supplement/research
- Value-for-money score
- 7 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Can help restore functional baseline